We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr Terragna - A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)
Carolina Terragna, PhD
Seràgnoli Institute of Hematology
Bologna, Italy
12.07.11

Be the first to comment

 related articles